IGF1R and neoplasm: The same group recently demonstrated that long-term CSF1R inhibitor treatment led to acquired resistance driven by a compensatory IGF1–IGF1R signaling loop between macrophages and tumor cells, resulting in enhanced glioma cell survival and invasion (134).